Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Field
-
and educational issues with the common goal of contributing to an inclusive, open and resourceful society. Your role In the context of Prof. Dr. Markus Miessen's post as Professor of Urban Regeneration
-
aims to achieve reliable genome design and synthesis – engineering cells to have specific functions – which will be a major milestone in modern biology. A dedicated social science program will support
-
5-year undergraduate nanotechnology programme and nanoscience graduate programme (https://phd.nat.au.dk/programmes/nanoscience/) the center provides a full educational environment. In
-
substantial knowledge and research experience in areas such as computational fluid dynamics, turbulence modeling, data-driven methodologies, machine learning, and parallel computing. The candidate should also
-
functional genomics and molecular mechanisms to lead the next phase of our causal target validation program. This role sits at the interface of cutting-edge genomic discovery, mechanistic biology, and
-
with you on board! RESEARCH PROJECT: Prof. Rutsch's research group investigates the molecular basis, pathogenetic principles, and therapeutic options for ectopic calcifications. We are currently looking
-
institute is expanding this approach to detect a wider range of biological molecules, including volatiles in human breath. In parallel, the Institute is developing state-of-the-art methods that integrate
-
work, animal studies, and computational biology. Payment is based on the Swiss National Science Foundation (SNSF)'s funding regulations for postdoctoral fellows. How to apply? Prof. Dr. med. Sebastian
-
unprecedented power to uncover cell-type-specific and cell-state-specific genetic mechanisms underlying human biology and disease. The Postdoc joining this program will have the opportunity to: Drive high-impact
-
are seeking for the next possible date a skilled and motivated Postdoc for the Division of Personalized Immunotherapies Reference number: 2025-0293 The Division of Personalized Immunotherapy (headed by Prof. Dr